Market Overview:
The global diabetic injection pen market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in diabetic injection pens, and rising demand for disposable pens. Based on type, the global diabetic injection pen market is segmented into reusable pens and disposable pens. The disposable pen segment is expected to grow at a higher CAGR than the reusable pen segment during the forecast period from 2018 to 2030. This can be attributed to factors such as ease of use and disposal, lower cost, and increasing preference for disposables over reusable pens among patients with diabetes. Based on application, the global diabetic injection pen market is divided into hospital pharmacy, retail pharmacy, online sales channels (such as e-commerce websites), and diabetes clinics/centers.
Product Definition:
A diabetic injection pen is a device used to inject insulin. It is important for people with diabetes to use an injection pen because it ensures that the insulin is delivered accurately and efficiently.
Reusable Pens:
Reusable pens are used by diabetic patients for injecting insulin. The reusable pen is a thin metal body with two or more needles attached to it. One end of the needle is connected to an ink cartridge and the other end can be connected to a diabetes patient's vein through which insulin can be injected.
Disposable Pens:
Disposable pens are used for writing and drawing purposes. They consist of a metal or plastic body, which is often covered with rubber to facilitate the writing and drawing. The product has different forms such as ballpoint pen, rollerball pen, gel pen etc., available in various colors including blue, black & white etc. Disposable pens are widely used by students of all age groups because they help them save their time while preparing any kind of exam sheets.
Application Insights:
The hospital pharmacy segment accounted for the largest share of 60.0% in 2017 owing to the high usage rates of insulin and other diabetic injection pens in hospitals. The growing number of diabetes patients coupled with rising prevalence is expected to drive the demand for these pens over the forecast period.
The retail pharmacy segment is anticipated to witness significant growth over the forecast period due to increasing penetration rate and awareness programs conducted by manufacturers, government bodies, non-profit organizations and others related entities. For instance, as per a study published by Diabetes UK in 2018, around 40% of people with diabetes have visited a pharmacist about their medication needs while 20% have done so through online resources or apps only; thus driving demand from retail pharmacies over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about diabetes and its treatment, presence of well-established healthcare facilities, availability of advanced products, and high patient disposable income. Moreover, rising prevalence of chronic diseases such as cardiovascular disorders and respiratory problems due to unhealthy lifestyles will boost product demand further.
The key players operating in this industry include B Braun Melsungen AG; Cipla Inc.; Dr Reddy's Laboratories Ltd.; FUJIFILM DIABETES CARE CO., LTD.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for diabetic injection pens, which can help in administering insulin doses accurately and conveniently.
- Technological advancements: The diabetic injection pen market is witnessing rapid technological advancements, with manufacturers introducing new products that are more user-friendly and offer greater accuracy in dosing insulin doses. This is helping to drive the market growth significantly.
- Rising awareness about diabetes management: There has been a significant rise in awareness about diabetes management in recent years, thanks to various campaigns by healthcare organizations as well as governments across the world. This has led to an increase in demand for devices such as diabetic injection pens that can help diabetics manage their condition effectively and safely .
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetic Injection Pen Market Research Report
By Type
Reusable Pens, Disposable Pens
By Application
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers
By Companies
Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca Plc, Biocon Ltd., Sanofi S.A., Becton,Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co., Wockhardt Ltd., Novo Nordisk A/S
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
226
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Diabetic Injection Pen Market Report Segments:
The global Diabetic Injection Pen market is segmented on the basis of:
Types
Reusable Pens, Disposable Pens
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk A/S
- Eli Lilly and Company
- AstraZeneca Plc
- Biocon Ltd.
- Sanofi S.A.
- Becton,Dickinson and Company
- Owen Mumford Ltd.
- Jiangsu Delfu Co.
- Wockhardt Ltd.
- Novo Nordisk A/S
Highlights of The Diabetic Injection Pen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Pens
- Disposable Pens
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetic Injection Pen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diabetic injection pen is a device that helps people with diabetes to inject insulin. The pen has a cartridge filled with insulin, and it can be used to inject the insulin into the body.
Some of the key players operating in the diabetic injection pen market are Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca Plc, Biocon Ltd., Sanofi S.A., Becton,Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co., Wockhardt Ltd., Novo Nordisk A/S.
The diabetic injection pen market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetic Injection Pen Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Diabetic Injection Pen Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Diabetic Injection Pen Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Diabetic Injection Pen Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Diabetic Injection Pen Market Size & Forecast, 2018-2028 4.5.1 Diabetic Injection Pen Market Size and Y-o-Y Growth 4.5.2 Diabetic Injection Pen Market Absolute $ Opportunity
Chapter 5 Global Diabetic Injection Pen Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diabetic Injection Pen Market Size Forecast by Type
5.2.1 Reusable Pens
5.2.2 Disposable Pens
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diabetic Injection Pen Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diabetic Injection Pen Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Sales
6.2.4 Diabetes Clinics/ Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetic Injection Pen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetic Injection Pen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diabetic Injection Pen Analysis and Forecast
9.1 Introduction
9.2 North America Diabetic Injection Pen Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diabetic Injection Pen Market Size Forecast by Type
9.6.1 Reusable Pens
9.6.2 Disposable Pens
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diabetic Injection Pen Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Sales
9.10.4 Diabetes Clinics/ Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diabetic Injection Pen Analysis and Forecast
10.1 Introduction
10.2 Europe Diabetic Injection Pen Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diabetic Injection Pen Market Size Forecast by Type
10.6.1 Reusable Pens
10.6.2 Disposable Pens
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diabetic Injection Pen Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Sales
10.10.4 Diabetes Clinics/ Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diabetic Injection Pen Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diabetic Injection Pen Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diabetic Injection Pen Market Size Forecast by Type
11.6.1 Reusable Pens
11.6.2 Disposable Pens
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diabetic Injection Pen Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Sales
11.10.4 Diabetes Clinics/ Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diabetic Injection Pen Analysis and Forecast
12.1 Introduction
12.2 Latin America Diabetic Injection Pen Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diabetic Injection Pen Market Size Forecast by Type
12.6.1 Reusable Pens
12.6.2 Disposable Pens
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diabetic Injection Pen Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Sales
12.10.4 Diabetes Clinics/ Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diabetic Injection Pen Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diabetic Injection Pen Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diabetic Injection Pen Market Size Forecast by Type
13.6.1 Reusable Pens
13.6.2 Disposable Pens
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diabetic Injection Pen Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Sales
13.10.4 Diabetes Clinics/ Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetic Injection Pen Market: Competitive Dashboard
14.2 Global Diabetic Injection Pen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novo Nordisk A/S
14.3.2 Eli Lilly and Company
14.3.3 AstraZeneca Plc
14.3.4 Biocon Ltd.
14.3.5 Sanofi S.A.
14.3.6 Becton,Dickinson and Company
14.3.7 Owen Mumford Ltd.
14.3.8 Jiangsu Delfu Co.
14.3.9 Wockhardt Ltd.
14.3.10 Novo Nordisk A/S